These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 24950003

  • 1. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2014 Oct; 88(2):483-91. PubMed ID: 24950003
    [Abstract] [Full Text] [Related]

  • 2. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 3. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of tableting and tablet properties of Kollidon SR: the influence of moisture and mixtures with theophylline monohydrate.
    Hauschild K, Picker-Freyer KM.
    Pharm Dev Technol; 2006 Feb; 11(1):125-40. PubMed ID: 16544916
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
    Rojas J, Kumar V.
    Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
    [Abstract] [Full Text] [Related]

  • 6. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A, Souto C, Marti Nez-Pacheco R, Concheiro A, Gómez-Amoza JL.
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [Abstract] [Full Text] [Related]

  • 7. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [Abstract] [Full Text] [Related]

  • 8. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P, Schröder M, Schultz P, Müller BW, Waaler T, Nymo L.
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [Abstract] [Full Text] [Related]

  • 9. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

  • 10. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M.
    Drug Dev Ind Pharm; 2008 Mar 16; 34(3):289-96. PubMed ID: 18363144
    [Abstract] [Full Text] [Related]

  • 11. Drug release from MCC- and carrageenan-based pellets: experiment and theory.
    Kranz H, Jürgens K, Pinier M, Siepmann J.
    Eur J Pharm Biopharm; 2009 Oct 16; 73(2):302-9. PubMed ID: 19465119
    [Abstract] [Full Text] [Related]

  • 12. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
    Salameh AK, Taylor LS.
    J Pharm Sci; 2006 Feb 16; 95(2):446-61. PubMed ID: 16380975
    [Abstract] [Full Text] [Related]

  • 13. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
    Krueger C, Thommes M.
    Pharm Dev Technol; 2013 Feb 16; 18(1):225-35. PubMed ID: 22780876
    [Abstract] [Full Text] [Related]

  • 14. Extrusion-Spheronization of blends of carbopol 934 and microcrystalline cellulose.
    Gómez-Carracedo A, Alvarez-Lorenzo C, Gómez-Amoza JL, Martínez-Pacheco R, Souto C, Concheiro A.
    Drug Dev Ind Pharm; 2001 May 16; 27(5):381-91. PubMed ID: 11448045
    [Abstract] [Full Text] [Related]

  • 15. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use.
    Hoang Thi TH, Lhafidi S, Carneiro SP, Flament MP.
    Int J Pharm; 2015 Dec 30; 496(2):842-9. PubMed ID: 26403385
    [Abstract] [Full Text] [Related]

  • 16. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Pharm Dev Technol; 2010 Dec 30; 15(6):626-35. PubMed ID: 20148708
    [Abstract] [Full Text] [Related]

  • 17. Combined effects of wetting, drying, and microcrystalline cellulose type on the mechanical strength and disintegration of pellets.
    Balaxi M, Nikolakakis I, Kachrimanis K, Malamataris S.
    J Pharm Sci; 2009 Feb 30; 98(2):676-89. PubMed ID: 18548618
    [Abstract] [Full Text] [Related]

  • 18. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS, Tank J, Suryanarayanan R.
    J Pharm Sci; 2007 May 30; 96(5):1434-44. PubMed ID: 17455350
    [Abstract] [Full Text] [Related]

  • 19. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools.
    Gurram RK, Gandra S, Shastri NR.
    Eur J Pharm Sci; 2016 Mar 10; 84():146-56. PubMed ID: 26812204
    [Abstract] [Full Text] [Related]

  • 20. How to improve the storage stability of aqueous polymeric film coatings.
    Siepmann F, Muschert S, Leclercq B, Carlin B, Siepmann J.
    J Control Release; 2008 Feb 18; 126(1):26-33. PubMed ID: 18068259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.